Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 475

1.

Low-dose Aspirin Use Does Not Increase Survival in 2 Independent Population-based Cohorts of Patients With Esophageal or Gastric Cancer.

Spence AD, Busby J, Johnston BT, Baron JA, Hughes CM, Coleman HG, Cardwell CR.

Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36332-1. doi: 10.1053/j.gastro.2017.10.044. [Epub ahead of print]

PMID:
29122547
2.

RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Murphy CC, Sanoff HK, Stitzenberg KB, Baron JA, Sandler RS, Yang YC, Lund JL.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx104. No abstract available.

PMID:
29117391
3.

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

Anderson JC, Morris CB, Robertson DJ, Barry ELR, Figueiredo JC, Cruz-Correa M, Bostick RM, Ahnen DJ, Baron JA.

J Clin Gastroenterol. 2017 Aug 1. doi: 10.1097/MCG.0000000000000899. [Epub ahead of print]

PMID:
28767463
4.

Associations between prenatal arsenic exposure with adverse pregnancy outcome and child mortality.

Shih YH, Islam T, Hore SK, Sarwar G, Shahriar MH, Yunus M, Graziano JH, Harjes J, Baron JA, Parvez F, Ahsan H, Argos M.

Environ Res. 2017 Oct;158:456-461. doi: 10.1016/j.envres.2017.07.004. Epub 2017 Aug 1.

PMID:
28692928
5.

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA.

J Clin Oncol. 2017 Aug 20;35(24):2806-2813. doi: 10.1200/JCO.2017.72.3569. Epub 2017 Jun 15.

PMID:
28617623
6.

Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.

Rees JR, Morris CB, Peacock JL, Ueland PM, Barry EL, McKeown-Eyssen GE, Figueiredo JC, Snover DC, Baron JA.

Cancer Prev Res (Phila). 2017 Aug;10(8):451-458. doi: 10.1158/1940-6207.CAPR-16-0278. Epub 2017 Jun 9.

PMID:
28600398
7.

Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab.

Baron JA.

JAAD Case Rep. 2017 Apr 14;3(3):215-218. doi: 10.1016/j.jdcr.2017.02.016. eCollection 2017 May. No abstract available.

8.

Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.

Andrew AS, Baron JA, Butterly LF, Suriawinata AA, Tsongalis GJ, Robinson CM, Amos CI.

Int J Mol Sci. 2017 Mar 2;18(3). pii: E535. doi: 10.3390/ijms18030535.

9.

Patterns of Sociodemographic and Clinicopathologic Characteristics of Stages II and III Colorectal Cancer Patients by Age: Examining Potential Mechanisms of Young-Onset Disease.

Murphy CC, Sanoff HK, Stitzenberg KB, Baron JA, Lund JL, Sandler RS.

J Cancer Epidemiol. 2017;2017:4024580. doi: 10.1155/2017/4024580. Epub 2017 Jan 23.

10.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

PMID:
28219690
11.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA.

Mol Carcinog. 2017 Aug;56(8):1977-1983. doi: 10.1002/mc.22629. Epub 2017 Mar 6.

PMID:
28218420
12.

Colorectal Cancer in Older Ages: What's Ahead?

Murphy CC, Baron JA.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):901-902. doi: 10.1016/j.cgh.2017.01.019. Epub 2017 Jan 28. No abstract available.

PMID:
28143729
13.

Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.

Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, Baron JA.

JAMA Oncol. 2017 May 1;3(5):628-635. doi: 10.1001/jamaoncol.2016.5917.

PMID:
27978548
14.

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers.

Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375. doi: 10.1158/1055-9965.EPI-16-0496. Epub 2016 Nov 3.

PMID:
27811119
15.

Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults.

Rees JR, Mott LA, Barry EL, Baron JA, Bostick RM, Figueiredo JC, Bresalier RS, Robertson DJ, Peacock JL.

J Nutr. 2016 Nov;146(11):2312-2324. Epub 2016 Sep 28.

16.

Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.

Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):903-909.e6. doi: 10.1016/j.cgh.2016.08.037. Epub 2016 Sep 5.

PMID:
27609707
17.

Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer.

Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Gallinger S, Giovannucci EL, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jeon J, Jenkins MA, Kocarnik J, Küry S, Le Marchand L, Lin Y, Lindor NM, Nishihara R, Ogino S, Potter JD, Rudolph A, Schoen RE, Schrotz-King P, Seminara D, Slattery ML, Thibodeau SN, Thornquist M, Toth R, Wallace R, White E, Jiao S, Lemire M, Hsu L, Peters U; CCFR and GECCO.

PLoS Genet. 2016 Oct 10;12(10):e1006296. doi: 10.1371/journal.pgen.1006296. eCollection 2016 Oct.

18.

A prognostic model for advanced colorectal neoplasia recurrence.

Liu L, Messer K, Baron JA, Lieberman DA, Jacobs ET, Cross AJ, Murphy G, Martinez ME, Gupta S.

Cancer Causes Control. 2016 Oct;27(10):1175-85. doi: 10.1007/s10552-016-0795-5. Epub 2016 Aug 12.

19.

Randomized controlled trials: who fails run-in?

Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL.

Trials. 2016 Jul 29;17:374. doi: 10.1186/s13063-016-1451-9.

20.

Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.

Stoffel EM, Erichsen R, Frøslev T, Pedersen L, Vyberg M, Koeppe E, Crockett SD, Hamilton SR, Sørensen HT, Baron JA.

Gastroenterology. 2016 Nov;151(5):870-878.e3. doi: 10.1053/j.gastro.2016.07.010. Epub 2016 Jul 19.

Supplemental Content

Loading ...
Support Center